Showing 641 - 660 results of 2,489 for search '"Diabetes mellitus"', query time: 0.11s Refine Results
  1. 641
  2. 642

    Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus by Wei Song, Jianxuan Wen, Jinming Zhang, Meng Luo, Yue Hu, Yu Zhang, Guanjie Fan, Ling Zhao

    Published 2023-01-01
    “…Hyperglycemia is common and difficult to control in perioperative patients with type 2 diabetes mellitus (T2DM), which impacts their prognosis after operation. …”
    Get full text
    Article
  3. 643
  4. 644
  5. 645
  6. 646
  7. 647

    Evaluation of home based insulin therapy among pediatric patients with type I diabetes mellitus - A prospective analytical study by Soundararajan N, Thangavel A, Vidjeadevan D, Annamalai Vijayaraghavan

    Published 2024-10-01
    “…Background: Home based insulin therapy is one of the major challenges faced by the Type I diabetes mellitus (T1DM) patients with regards to the injection technique and correct dosing. …”
    Get full text
    Article
  8. 648

    Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients by Lingshu Wang, Jun Song, Chuan Wang, Peng Lin, Kai Liang, Yu Sun, Tianyi He, Wenjuan Li, Ruxing Zhao, Jun Qin, Yiran Lu, Jinbo Liu, Fuqiang Liu, Xinguo Hou, Li Chen

    Published 2016-01-01
    “…The present study aims to demonstrate the associations of circulating betatrophin and irisin levels with β-cell function, assessed by the area under the curve (AUC) of C-peptide, and the possible correlation between these two hormones in previously diagnosed type 2 diabetes mellitus (T2DM) patients. In total, 20 age-, sex-, and body mass index- (BMI-) matched normal glucose tolerance (NGT) subjects and 120 previously diagnosed T2DM patients were included in this study. …”
    Get full text
    Article
  9. 649

    Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients by Esmat Khaleqsefat, Khder Hussein Rasul, Ramiar Kamal Kheder, Sonia Baban, Jamil Baban

    Published 2025-01-01
    “…Abstract Dyslipidemia, an imbalance in blood lipid levels, is a frequent complication of type 2 diabetes mellitus (DM2) and heightens the risk of cardiovascular diseases (CVDs). …”
    Get full text
    Article
  10. 650
  11. 651
  12. 652

    Proceso atención de enfermería en un paciente con diabetes mellitus tipo 2, sin mención de complicación by Edith Verónica Vivanco Jacobe, Jose Cristhian Huayhuas Flores, Any Rúa Echaccaya, Jasmin Melisa Ponce Lozada, María Angélica Fuentes Siles, Yurik Anatoli Suárez Valderrama

    Published 2023-08-01
    “…Caso clínico: Paciente adulta de 50 años, con antecedentes familiares de diabetes mellitus tipo 2. Llega a la clínica por control de colesterol y peso, donde le toman análisis de sangre; en el resultado de perfil lipídico se observa colesterol, triglicéridos y glucosa elevados. …”
    Get full text
    Article
  13. 653

    Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19 by Chi Nguyen, Christopher L. Crowe, Effie Kuti, Bonnie Donato, Rachel Djaraher, Leo Seman, Nancy Graeter, Thomas P. Power, Rinku Mehra, Vincent J. Willey

    Published 2024-04-01
    “…**Background:** The economic burden associated with type 2 diabetes mellitus (T2DM) and concurrent cardiovascular disease (CVD) among patients with COVID-19 is unclear. …”
    Get full text
    Article
  14. 654
  15. 655
  16. 656

    Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus by Lucia Saucedo, Isabel B. Pfister, Souska Zandi, Christin Gerhardt, Justus G. Garweg

    Published 2021-01-01
    “…Diabetic retinopathy (DR) is a sight-threatening late complication of diabetes mellitus (DM). Even though its pathophysiology has not been fully elucidated, several studies suggested a role for transforming growth factor- (TGF-) β, matrix metalloproteinases (MMPs), and tissue inhibitors of matrix metalloproteinase (TIMP) in the onset and progression of the disease. …”
    Get full text
    Article
  17. 657
  18. 658

    Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study by Yoshiro Fushimi, Atsushi Obata, Junpei Sanada, Yuichiro Iwamoto, Akiko Mashiko, Megumi Horiya, Akiko Mizoguchi-Tomita, Momoyo Nishioka, Yuki Kan, Tomoe Kinoshita, Seizo Okauchi, Hidenori Hirukawa, Kenji Kohara, Fuminori Tatsumi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto

    Published 2020-01-01
    “…Recently, dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors have been very often used in subjects with type 2 diabetes mellitus (T2DM). In addition, combination drugs of both inhibitors have attracted much attention in aspects of its cost-effectiveness and improvement of patients’ adherence. …”
    Get full text
    Article
  19. 659
  20. 660

    Effect of Admission Hyperglycemia on Short-Term Prognosis of Patients with Non-ST Elevation Acute Coronary Syndrome without Diabetes Mellitus by Wei Liu, Zhijuan Li, Shiying Xing, Yanwei Xu

    Published 2021-01-01
    “…To evaluate the effect of admission hyperglycemia on the short-term prognosis of patients with non-ST elevation acute coronary syndrome (NSTE-ACS) without diabetes mellitus. Methods. The clinical data of 498 patients with NSTE-ACS admitted to the Department of Cardiology of the First Affiliated Hospital of Henan University of Science and Technology between March 2018 and November 2020 were analyzed. …”
    Get full text
    Article